MIT’s Recursive Language Models rethink AI memory by treating documents like searchable environments, enabling models to ...

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A new orchestration approach, called Orchestral, is betting that enterprises and researchers want a more integrated way to ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

A Texas couple transformed the 945-square-foot room into a space where they could watch sports and entertain friends. One brings the snow, while the other is all about the sun. Both pack a pricey ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

AI companies are engaged in an expensive arms race to attract users and alleviate public anxiety about the technology. The move taps one of the most senior women on Wall Street to help lead the ...